Evaluating Implementation Strategies to Scale-up Transdiagnostic Evidence-based Mental Health Care in Zambia
Key facts
- Who runs it
- Centre for Infectious Disease Research in Zambia
- Where
- Zambia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 456 people enrolled
- Started
- 25 Feb 2020
- Ended
- 29 Feb 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- In-person CETA
- Telephone CETA
- Treatment as Usual (TAU)
- Record updated
- 7 June 2024
Who can take part
- Age
- 15 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 23 criteriaShow less
Other criteria
- CETA Counselors
- Inclusion:
- 18 years of age or older
- Interest in providing CETA
- Time/availability to participate in the study
- Minimal education level is comparable to a high school education
- Ability to speak English fluently and speak at least 1 local language (Nyanja or Bemba)
- Completion of an in-person interview with study team investigators demonstrating strong communication skills
- Planning to stay in study area (Lusaka) to provide treatment to clients; Exclusion:
- If previously trained in CETA; CETA Trainers; Inclusion:
- All eligibility criteria for CETA counselors
- Interest in teaching CETA
- Completion of the CETA training
- Completion of a minimum of 3 CETA cases under supervision; Adolescent/Young Adult (AYA) Clients; Inclusion:
- 15-29 years of age
- Attend or be referred to study site
- Live in the area served by a study site (i.e., not staying temporarily)
- Ability to speak one of the study languages (English, Bemba, or Nyanja)
- Screening: Present with one or more common mental/behavioral health problems based on validated screening tools included in the audio computer assisted self-interviewing (ACASI) system. Specifically, the following screening tools and cut-off values:; Youth Self Report Internalizing Scale (≥14); Youth Self Report Externalizing Scale (≥8); Child PTSD Symptom Scale (≥11.5); Exclusion:
- Currently on unstable psychiatric drug regimen (e.g., altered in past two months)
- Suicide attempt or active and severe self-harm in past month
- Psychotic disorder or severe mental illness; Research/Organizational Staff; Inclusion:
- Involved in development and/or implementation of the technology training platform, including clinical, research, and web development staff
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study utilizes a Hybrid Type 1 multi-arm parallel group randomized control design to compare the effectiveness of an evidence-based treatment (CETA) delivered either in-person or via telephone, compared with a treatment as usual (TAU) control group, on improving adolescent and young adult (AYA) mental and behavioral health outcomes. The study will also gather information on counselor treatment knowledge, fidelity and competency following a technology-delivered training. Lastly, the cost associated with these strategies will be explored to inform future scale-up of training and services. This study will be conducted in Lusaka, Zambia and participants will be enrolled at four different levels: prospective CETA trainers, prospective CETA counselors, AYA clients, and research/organizational staff. AYA clients are the primary participant type.
The 3 groups in the trial
- In-person CETATreatment being tested
This is the in-person delivery method of the Common Elements Treatment Approach (CETA).
- Telephone CETA (T-CETA)Treatment being tested
This is the technology-based delivery method for the Common Elements Treatment Approach (CETA).
Treatment: Telephone CETA
- Treatment As UsualExisting treatment, for comparison
This is the treatment as usual control condition who will engage with their usual care in the community and will receive CETA, if desired, following completion of the study.
Treatment: Treatment as Usual (TAU)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 7 June 2024